Status:
NOT_YET_RECRUITING
Comparing IVF/ICSI Cycle Outcomes of Post Ovulation Ovarian Stimulation Protocol With Elonva Without GnRH Antagonist to Follicular Phase Day 2 Stimulation Fixed Day 5 Antagonist Protocol
Lead Sponsor:
ART Fertility Clinics LLC
Conditions:
Stimulation in the Ovary
IVF Outcome
Eligibility:
FEMALE
18-38 years
Brief Summary
There are several approaches to the timing of antagonist administration in IVF/ICSI cycles. The primary goal is indeed to prevent premature ovulation, which could jeopardize the success of the cycle T...
Eligibility Criteria
Inclusion
- Age 18 to 38 years old.
- Normal Menstrual cycle of 25-35 days.
- Body Weight 60to90 kg
- AMH\>1.3 - \<3 ng/m (Ferraretti and Gianaroli, 2014; Calzada et al., 2019) an antral follicle count (AFC) of \>5 on menstrual cycle days 2-3,
Exclusion
- History of premature ovulation
- Azoospermia
- PCOS
- Endometriosis AFS ¾
- Endometrioma
- Known chromosomal abnormalities
Key Trial Info
Start Date :
December 30 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2026
Estimated Enrollment :
252 Patients enrolled
Trial Details
Trial ID
NCT06879002
Start Date
December 30 2025
End Date
December 30 2026
Last Update
October 2 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
ART Fertility Clinics LLC
Abu Dhabi, United Arab Emirates
2
ART Fertility Clinics LLC - Dubai
Dubai, United Arab Emirates